JPH07121345B2 - Non-adsorbing hydrophilic semipermeable membrane and method for producing the same - Google Patents
Non-adsorbing hydrophilic semipermeable membrane and method for producing the sameInfo
- Publication number
- JPH07121345B2 JPH07121345B2 JP61142735A JP14273586A JPH07121345B2 JP H07121345 B2 JPH07121345 B2 JP H07121345B2 JP 61142735 A JP61142735 A JP 61142735A JP 14273586 A JP14273586 A JP 14273586A JP H07121345 B2 JPH07121345 B2 JP H07121345B2
- Authority
- JP
- Japan
- Prior art keywords
- membrane
- hydroxyl group
- polysulfone
- neutral hydroxyl
- hydrophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000012528 membrane Substances 0.000 title claims description 50
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 229920002492 poly(sulfone) Polymers 0.000 claims description 25
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- 239000000178 monomer Substances 0.000 claims description 14
- 230000007935 neutral effect Effects 0.000 claims description 12
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 claims description 10
- 230000000274 adsorptive effect Effects 0.000 claims description 5
- 102000034238 globular proteins Human genes 0.000 claims description 5
- 108091005896 globular proteins Proteins 0.000 claims description 5
- 239000002243 precursor Substances 0.000 claims description 5
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical group CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 4
- 230000005865 ionizing radiation Effects 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 3
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000002585 base Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 7
- 238000010559 graft polymerization reaction Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000010894 electron beam technology Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 239000012510 hollow fiber Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229940095095 2-hydroxyethyl acrylate Drugs 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- -1 Enol esters Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000021523 carboxylation Effects 0.000 description 2
- 238000006473 carboxylation reaction Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000006277 sulfonation reaction Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 229940044192 2-hydroxyethyl methacrylate Drugs 0.000 description 1
- 102000000546 Apoferritins Human genes 0.000 description 1
- 108010002084 Apoferritins Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0093—Chemical modification
- B01D67/00931—Chemical modification by introduction of specific groups after membrane formation, e.g. by grafting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/66—Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
- B01D71/68—Polysulfones; Polyethersulfones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/38—Graft polymerization
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、製薬工業等における各種薬品よりなる注射
薬、輸液、バルク原液、又は用水等の除菌、除パイロジ
エン精製に好適な親水性半導膜及びその製造方法に関す
る。DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] The present invention provides a hydrophilic semi-preservative suitable for sterilization of injectables, infusions, bulk stock solutions, water for use, etc., consisting of various chemicals in the pharmaceutical industry, etc. The present invention relates to a conductive film and a manufacturing method thereof.
従来、製薬工業においては、その製造された各種薬液よ
り菌又はパイロジエンを除去するにあたり、多くの限外
過膜が使用されている。Conventionally, in the pharmaceutical industry, in order to remove bacteria or pyrodiene from the produced various chemical solutions, many ultrapermeable membranes have been used.
それらの限外過膜としては一般にポリスルホン(ポリ
エーテルスルホン等も含む)が材料として使用される
が、これはポリスルホンが比較的耐熱性にすぐれてお
り、かつ製膜され易いからである。Polysulfone (including polyether sulfone and the like) is generally used as a material for these ultrafiltration membranes, because polysulfone has relatively excellent heat resistance and is easily formed into a membrane.
一方、ポリスルホンは例えばポリアクリロニトリル、ポ
リアミド等と異なり比較的疎水性であるので、膜をその
まま乾燥させると、再び水に浸漬しても容易にその元の
過性能に回復しない。On the other hand, polysulfone is relatively hydrophobic unlike, for example, polyacrylonitrile, polyamide, etc., so that if the membrane is dried as it is, it will not easily recover its original overperformance even if it is immersed in water again.
さらに、ポリスルホンは、製膜技術だけで分画分子量を
下げる事が難かしく、スルホン化、カルボキシル化等の
処理を必要とした。Furthermore, it was difficult to lower the molecular weight cut-off of polysulfone only by the film-forming technique, and thus treatments such as sulfonation and carboxylation were required.
さらにスルホン化又はカルボキシル化は、水の過(脱
塩機能)用には有効であるが、この膜で蛋白質製剤液を
精製した場合、往々にして蛋白質の吸着又は変質が見ら
れる。Further, sulfonation or carboxylation is effective for excess of water (desalting function), but when a protein preparation liquid is purified with this membrane, adsorption or deterioration of the protein is often observed.
本発明は製薬工業等の輸液、注射液又はプロセス用水よ
り、菌やパイロジエン状物質を除去するに際し、膜が乾
燥しても再び過性能が容易に回復出来、かつ液が変
質しない有用な半透膜を提供するものである。INDUSTRIAL APPLICABILITY The present invention is a useful semipermeable membrane for removing bacteria and pyrodiene-like substances from infusion solutions, injection solutions or process water of the pharmaceutical industry, etc., even when the membrane is dried, the overperformance can be easily recovered and the solution does not deteriorate. A membrane is provided.
さらに、極めて小分子量の蛋白質もカツト出来るポリス
ルホン系半透膜を提供するものである。Further, the present invention provides a polysulfone-based semipermeable membrane capable of cutting a protein having an extremely small molecular weight.
ここに本発明者は、上記課題を解決する半透膜を鋭意研
究した結果、以下の手段により達成されることが判つ
た。Here, as a result of earnest research on a semipermeable membrane which solves the above-mentioned problems, the present inventor has found that it can be achieved by the following means.
すなわち、基材膜の材質がポリスルホンである半透膜
に、中性ヒドロキシル基を含む側鎖がグラフトされ、か
つ中性ヒドロキシル基含有率が膜1グラム当り0.1ない
し8ミリ当量である、球状蛋白による分画分子量が100
万以下の非吸着性親水性膜によつて、極めて効果的に課
題が解決されることが判つた。That is, a spherical protein in which a side chain containing a neutral hydroxyl group is grafted to a semipermeable membrane whose base material is polysulfone and the content of the neutral hydroxyl group is 0.1 to 8 meq / g of the membrane. Molecular weight cut off by 100
It has been found that the problem can be solved very effectively by using less than 10,000 non-adsorbing hydrophilic films.
以下本発明について更に具体的詳細に説明する。The present invention will be described in more detail below.
本発明においてグラフト処理される基材膜は、ポリスル
ホン膜であることが必要で、これは半透膜材料としての
充分な機械的性質を保持しているからである。The base material membrane to be graft-treated in the present invention is required to be a polysulfone membrane, because it has sufficient mechanical properties as a semipermeable membrane material.
次に、この疎水性ポリスルホン膜にグラフトされるモノ
マーとしては、1個以上の中性ヒドロキシル基(アルコ
ール性水酸基)あるいはその前駆体となる官能基を有
し、かつ、グラフト可能でなくてはならない。具体的に
は、2−ヒドロキシエチル−アクリレート、2−ヒドロ
キシルエチル−メタクリレート等のアクリル酸又はメタ
クリル酸と多価アルコールのエステル類、及びアリルア
ルコール等の不飽和結合を有するアルコール類、及び酢
酸ビニル、プロピオン酸ビニル等のエノールエステル類
が挙げられる。特に好ましいのは不飽和結合を有するア
ルコール類及びエノールエステル類である。例えばアリ
ルアルコール等を前記疎水性膜へグラフトすることによ
り、又、酢酸ビニル等をグラフトし、その後加水分解さ
せることにより、所望とする中性水酸基を含む側鎖をも
つ非吸着性水性膜を得ることができる。しかも、このよ
うにして得られたものについては2−ヒドロキシエチル
−アクリレート等を用いた場合と異なり、エステル結合
を有しないため、側鎖は化学的に極めて安定であり、
酸、アルカリ等の条件下においても容易には科学変化を
起こさない。Next, the monomer to be grafted to the hydrophobic polysulfone membrane must have at least one neutral hydroxyl group (alcoholic hydroxyl group) or a functional group as a precursor thereof, and must be graftable. . Specifically, esters of acrylic acid or methacrylic acid such as 2-hydroxyethyl-acrylate and 2-hydroxyethyl-methacrylate with polyhydric alcohols, alcohols having unsaturated bonds such as allyl alcohol, and vinyl acetate, Enol esters such as vinyl propionate may be mentioned. Particularly preferred are alcohols and enol esters having unsaturated bonds. For example, by grafting allyl alcohol or the like onto the hydrophobic membrane, or by grafting vinyl acetate or the like and then hydrolyzing it, a non-adsorptive aqueous membrane having a desired side chain containing a neutral hydroxyl group is obtained. be able to. Moreover, in the case of the product thus obtained, unlike the case where 2-hydroxyethyl-acrylate or the like is used, since the compound does not have an ester bond, the side chain is chemically extremely stable,
It does not easily undergo scientific changes even under conditions such as acid and alkali.
かくして得られた側鎖中でのヒドロキシル基は任意にそ
の濃度を調整できるが、本発明の効果として、膜1グラ
ム当り0.1ないし8ミリ当量、好ましくは1ないし3ミ
リ当量が必要である。The concentration of the hydroxyl group in the side chain thus obtained can be arbitrarily adjusted, but the effect of the present invention is that 0.1 to 8 meq, preferably 1 to 3 meq is required per gram of the membrane.
ここで、膜1グラムとは、膜のかなりマクロ的な重量を
基準にした値のことであり、例えば膜表面の一部、又は
内部の一部だけを取り出した重量のことではない。基材
膜の優れた機械的性質を保持したまま親水化処理される
には、できるだけ孔の表面により優先的にグラフトされ
たほうが目的を達しやすい。したがつて、ここで言う基
材膜1グラムと言う意味は膜の全面にわたつて平等に加
味測定された値を示しており、ごく微視的な観点での重
量を意味していない。Here, 1 gram of the film is a value based on a considerably macroscopic weight of the film, and does not mean, for example, a weight obtained by taking out only a part of the film surface or a part of the inside. In order to carry out the hydrophilic treatment while maintaining the excellent mechanical properties of the base material film, it is easier to achieve the purpose by preferentially grafting the surface of the pores as much as possible. Therefore, the term "1 gram of the base film" as used herein means a value measured evenly over the entire surface of the film, and does not mean the weight from a microscopic viewpoint.
本発明によつて得られるグラフト化ポリスルホン膜は、
球状蛋白質の分子量で約100万以下の分画分子量を有し
ている。The grafted polysulfone membrane obtained according to the present invention is
It has a molecular weight cut-off of about 1 million or less in the globular protein.
こゝで球状蛋白質とは、水中又は血液中等でほぼ球形を
示すものを指し、例えばインシユリン(分子量6千)、
シトクロムC(同1万3千)、γグロブリン(同5
万)、ヘモグロビン(同6万)、アポフエリチン(同48
万)、免液グロブリン(沈降常数19s、分子量90万)等
を指している。Here, the globular protein refers to a globular protein that has a substantially spherical shape in water or blood, and examples thereof include insulin (molecular weight 6,000),
Cytochrome C (13,000 same), gamma globulin (5 same)
10,000), hemoglobin (60,000), apoferritin (48, same)
10,000) and liquid-free globulin (precipitation constant 19s, molecular weight 900,000).
分画分子量の測定は、規格として一律化されていない
が、ここでは蛋白質濃度0.025%の原液を圧力1Kg/cm2で
半透膜に通し、そのカツト率が95%以上になる蛋白質の
最少分子量を指す。The measurement of molecular weight cut-off is not standardized, but here the minimum molecular weight of a protein with a cut rate of 95% or more is obtained by passing a stock solution with a protein concentration of 0.025% through a semipermeable membrane at a pressure of 1 Kg / cm 2. Refers to.
ポリスルホン基材膜の形状は、平膜状、チユーブ状、中
空糸膜状のいずれも適用可能であるが、本発明の目的と
して内径0.1ないし10ミリ、厚み0.05ないし5ミリなる
形状を有する中空糸タイプのものが好ましい。The polysulfone base material membrane may be in the form of a flat membrane, a tube, or a hollow fiber membrane, but for the purpose of the present invention, a hollow fiber having an inner diameter of 0.1 to 10 mm and a thickness of 0.05 to 5 mm. The type is preferable.
本発明の親水性膜の官能基を基材膜にグラフトさせる方
法には、化学処理法等の方法もあるが、電離性放射線を
基材膜に照射する方法が最も良い。この方法では基材膜
を化学的に劣化させることが少ない、フリーの重合体が
出来にくい、及びこのようにして製造された半透膜が機
械的、化学的にも優れており、過性能が良いという利
点がある。The method of grafting the functional group of the hydrophilic film of the present invention onto the substrate film may be a method such as a chemical treatment method, but the method of irradiating the substrate film with ionizing radiation is the best. In this method, the base material film is less likely to be chemically deteriorated, a free polymer is hard to be formed, and the semipermeable membrane produced in this way is mechanically and chemically excellent, and the overperformance is It has the advantage of being good.
用いられる電離性放射線は、α線、β線、γ線、加速電
子線、X線などであるが、実用的には電子線又はγ線が
好ましい。グラフト重合させる方法としては、ポリスル
ホンの基材膜とモノマーの共存下に放射線を照射し、グ
ラフト重合させる同時放射法と、ポリスルホン基材膜の
みにあらかじめ放射線を照射し、その後ポリスルホン基
材膜にモノマーを接触反応させてグラフト重合させる前
照射法がある。同時照射法ではポリスルホン基材膜への
モノマーのグラフト重合が進行すると同時に、グラフト
重合に関与しないモノマーのみが単独重合し、ポリスル
ホン基材膜の空孔を閉塞するという問題が生じるので前
照射法が好ましい。前照射法では、ポリスルホン基材膜
にモノマーを接触させる以前に基材膜にあらかじめ放射
線を照射し、モノマーと接触させるまでの間マイナス10
℃以下に保ち、50℃以下、好ましくは15℃〜50℃の低温
でモノマーと接触させてグラフト重合を行なう。放射線
を照射したのちにポリスルホン基材膜を低温保存しない
場合は、生成ラジカルが急速に減衰し、室温(25℃)で
30分経過するとその数は半分になる。更に、それと同時
に生成ラジカルが微量の吸着酸素と反応し、目的物質の
耐熱耐薬品性を損なうという欠陥を生じる。又、グラフ
ト重合温度が60℃以上になると、グラフト重合にあずか
らないモノマーの単独熱重合物が生成し、ポリスルホン
膜の微孔を閉塞するとか、反応後の後処理工程では抽出
されない単独熱重合物が親水化の後に流出してきて二次
公害の原因となる、といつた問題が生じる。更に必要に
応じて、グラフト後、架橋剤の存在下又は非存在下状態
で、さらに電子線又はγ線照射させる事が出来る。The ionizing radiation used is α-rays, β-rays, γ-rays, accelerated electron rays, X-rays, etc., but electron rays or γ-rays are preferable for practical use. As the method of graft polymerization, irradiation is performed in the coexistence of a polysulfone base film and a monomer, and the simultaneous irradiation method of graft polymerization is used. There is a pre-irradiation method of contact-reacting and graft polymerizing. In the simultaneous irradiation method, since the graft polymerization of the monomer onto the polysulfone base material film proceeds, at the same time, only the monomer not involved in the graft polymerization is homopolymerized, which causes a problem that the pores of the polysulfone base material film are blocked. preferable. In the pre-irradiation method, before the monomer is brought into contact with the polysulfone substrate film, the substrate film is pre-irradiated with radiation, and the period of time before contacting with the monomer is minus 10
Graft polymerization is carried out by keeping the temperature below 50 ° C and contacting with the monomer at a low temperature below 50 ° C, preferably 15 ° C to 50 ° C. If the polysulfone base material film is not stored at low temperature after irradiation with radiation, the generated radicals are rapidly attenuated and the temperature is kept at room temperature (25 ° C).
The number halves after 30 minutes. At the same time, the generated radicals react with a small amount of adsorbed oxygen, resulting in a defect that the heat resistance and chemical resistance of the target substance are impaired. Further, when the graft polymerization temperature is 60 ° C or higher, a homopolymer of a monomer, which is not involved in the graft polymerization, is generated, which may block the micropores of the polysulfone membrane, or a homopolymer which is not extracted in the post-treatment step after the reaction. A problem arises that things flow out after being made hydrophilic and cause secondary pollution. Further, if necessary, after the grafting, electron beam or γ-ray irradiation can be performed in the presence or absence of the crosslinking agent.
以下、実施例により本発明の構成及び効果を具体的に述
べるが、いずれも本発明を限定するものではない。Hereinafter, the configuration and effects of the present invention will be specifically described by way of examples, but they do not limit the present invention.
実施例1及び比較例1 DMACを主溶剤として紡糸し、水中で凝固された外径1.3m
m、内径0.6mmのポリスルホン(銘柄P−3500。米U.C.C.
社製)半透性中空糸膜を凍結乾燥させ、電子加速器(加
圧電圧1.5MoV、電子線電流1mA)を用いて窒素雰囲気下1
00KGYで電子線を照射した後、あらかじめ溶存酸素を5pp
m以下にした酢酸ビニール蒸気にあててグラフトさせ
た。Example 1 and Comparative Example 1 DMAC was spun using the main solvent as the main solvent and coagulated in water to give an outer diameter of 1.3 m.
m, inner diameter 0.6mm polysulfone (brand P-3500. US UCC
Freeze-dry the semipermeable hollow fiber membrane, and use an electron accelerator (pressurization voltage 1.5MoV, electron beam current 1mA) in a nitrogen atmosphere 1
After irradiating an electron beam with 00KGY, dissolved oxygen was previously added to 5 pp
Grafting was applied to a vinyl acetate vapor having a size of m or less.
このグラフト膜をさらに80℃の苛性ソーダ30%水溶液で
合計24時間反応させ、分画分子量6,000、グラフト率3
ミリ当量/グラム膜の限外過膜(実施例膜−1)を得
た。The graft membrane was further reacted with a 30% aqueous solution of caustic soda at 80 ° C for a total of 24 hours, and the molecular weight cutoff was 6,000 and the graft ratio was 3
An ultrahypermembrane (Example membrane-1) having a milliequivalent / gram membrane was obtained.
一方、同じポリスルホン基材膜に同じく電子線を照射さ
せたのち、アクリル酸をグラフトさせて限外過膜(分
画分子量6,000、グラフト率2.5ミリ当量/グラム膜)を
得た(比較例膜−1)。On the other hand, the same polysulfone base material film was similarly irradiated with an electron beam, and then acrylic acid was grafted to obtain an ultrapermeation film (molecular weight cutoff of 6,000, graft ratio of 2.5 meq / g film) (comparative example film- 1).
なお、上記限外過膜は乾燥前にさらに電子線を20Mγ
照射し、その後架橋させた。In addition, the above ultrapermeability film was further irradiated with an electron beam of 20 Mγ before drying.
Irradiation followed by crosslinking.
さらに比較のために、未処理のポリスルホン膜(分画分
子量13,000)を比較例膜−2とした。Further, for comparison, an untreated polysulfone membrane (molecular weight cutoff of 13,000) was used as Comparative Example membrane-2.
これらの膜の過速度、及び水に浸漬した後いつたん乾
燥させて再び水に浸漬したときの透水速度保持率を以下
に示す。The overspeeds of these membranes and the water permeability retention rate when they are immersed in water, immediately dried and then immersed again in water are shown below.
さらに上記3種の膜の0.1%ビタミンB−12液の吸着性
を測定したところ、膜の蛋白への吸着性は以下のようで
あつた。 Further, when the adsorbability of 0.1% vitamin B-12 solution of the above three kinds of membranes was measured, the adsorbability of the membranes to proteins was as follows.
なお、浸漬液は浸漬後、比較例膜−2においてpHが酸性
側に0.1変化した。 The pH of the immersion liquid in the Comparative Example membrane-2 changed to 0.1 after the immersion.
実施例2および比較例2 実施例1とほぼ同じような方法で得られたポリスルホン
の中空糸状半透膜(外径1.0mm、内径0.5mm)に、アリル
アルコールを実施例1と同様な方法で電子線照射後グラ
フトさせ、実施例膜−2を得た。Example 2 and Comparative Example 2 Allyl alcohol was added to a hollow fiber semipermeable membrane of polysulfone (outer diameter 1.0 mm, inner diameter 0.5 mm) obtained by substantially the same method as in Example 1 in the same manner as in Example 1. After electron beam irradiation, grafting was carried out to obtain Example membrane-2.
また、実施例1の方法において溶剤および添加剤を調節
することにより、各種の分画分子量を有する比較例膜−
3、4を得た。これらの膜の透水速度及び、ビタミンB
−12(分子量1,000)の阻止率を以下に示す。Further, by adjusting the solvent and the additive in the method of Example 1, a comparative example membrane having various molecular weight cutoffs was prepared.
3 and 4 were obtained. Permeability of these membranes and vitamin B
The rejection rate of -12 (molecular weight 1,000) is shown below.
上記の結果は、膜の透水速度を極端に落しても、低い分
子量を有する蛋白質を高程度に阻止出来る性能を有する
半透膜は、ポリスルホン単独では困難であり、本発明に
よれば実現される事を示している。 The above results indicate that a semipermeable membrane having the ability to block a protein having a low molecular weight to a high degree even if the water permeability of the membrane is extremely reduced is difficult to achieve by polysulfone alone, and is realized by the present invention. It shows a thing.
なお、上記実施例1、2と比較例1におけるグラフト率
は、すべて重量法によつた。The graft ratios in Examples 1 and 2 and Comparative Example 1 were all determined by the gravimetric method.
本発明の膜は、そのままドライ状態で使用が可能であ
り、サニタリー性その他の多くの点で従来の製薬工業用
水をはじめとする液精製用限外過膜としてすぐれてい
る。The membrane of the present invention can be used as it is in a dry state, and is excellent in sanitary properties and many other points as a conventional ultrafiltration membrane for liquid purification including water for pharmaceutical industry.
さらに本発明によれば、透水速度を極端に落すことなく
分画分子量の低いポリスルホン膜が製造できるので、業
界の品質向上、収率アツプに役立つ。Furthermore, according to the present invention, a polysulfone membrane having a low molecular weight cut-off can be produced without significantly reducing the water permeation rate, which is useful for improving the quality and improving the yield in the industry.
Claims (6)
に、中性ヒドロキシル基を含む側鎖がグラフトされ、か
つ中性ヒドロキシル基含有率が膜1グラム当り0.1ない
し8ミリ当量である、球状蛋白による分画分子量が100
万以下の非吸着性親水性半透膜。1. A semipermeable membrane whose base material is polysulfone is grafted with side chains containing neutral hydroxyl groups, and the content of neutral hydroxyl groups is 0.1 to 8 milliequivalents per gram of membrane. , Molecular weight cut-off by globular protein is 100
10,000 or less non-adsorbing hydrophilic semi-permeable membrane.
重合体、又はアリルアルコールの単量体あるいは重合体
である特許請求の範囲第1項記載の非吸着性親水性半透
膜。2. The non-adsorbable hydrophilic semipermeable membrane according to claim 1, wherein the side chain is a vinyl alcohol monomer or polymer, or an allyl alcohol monomer or polymer.
ノマーを、基材膜の材質がポリスルホンである半透膜に
電離性放射線を照射することによりグラフトさせること
を特徴とする非吸着性親水性膜の製造方法。3. A non-adsorptive hydrophilic film, wherein a grafting monomer having a neutral hydroxyl group is grafted by irradiating a semipermeable membrane whose base material is polysulfone with ionizing radiation. Manufacturing method.
ノマーがアリルアルコールである特許請求の範囲第3項
記載の非吸着性親水性膜の製造方法。4. The method for producing a non-adsorptive hydrophilic film according to claim 3, wherein the grafting monomer having a neutral hydroxyl group is allyl alcohol.
ト性モノマーを、基材膜の材質がポリスルホンである半
透膜に電離性放射線を照射することによりグラフトさ
せ、その後前駆体を中性ヒドロキシル基へ誘導すること
を特徴とする非吸着性親水性膜の製造方法。5. A grafting monomer having a neutral hydroxyl group precursor is grafted by irradiating a semipermeable membrane whose base material is polysulfone with ionizing radiation, and then the precursor is neutral hydroxyl group. A method for producing a non-adsorptive hydrophilic membrane, characterized by inducing
ト性モノマーが酢酸ビニルであり、前駆体の中性ヒドロ
キシル基への誘導がエステル結合の加水分解である特許
請求の範囲第5項記載の非吸着性親水性膜の製造方法。6. The non-claim according to claim 5, wherein the grafting monomer having a neutral hydroxyl group precursor is vinyl acetate, and the induction of the precursor to a neutral hydroxyl group is hydrolysis of an ester bond. A method for producing an adsorptive hydrophilic membrane.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61142735A JPH07121345B2 (en) | 1986-06-20 | 1986-06-20 | Non-adsorbing hydrophilic semipermeable membrane and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61142735A JPH07121345B2 (en) | 1986-06-20 | 1986-06-20 | Non-adsorbing hydrophilic semipermeable membrane and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS631406A JPS631406A (en) | 1988-01-06 |
JPH07121345B2 true JPH07121345B2 (en) | 1995-12-25 |
Family
ID=15322358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61142735A Expired - Fee Related JPH07121345B2 (en) | 1986-06-20 | 1986-06-20 | Non-adsorbing hydrophilic semipermeable membrane and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07121345B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3085815A1 (en) | 2013-12-18 | 2016-10-26 | Kawasaki Jukogyo Kabushiki Kaisha | Diaphragm for alkaline water electrolysis, method for producing same, and alkaline water electrolysis apparatus |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6331501A (en) * | 1986-07-25 | 1988-02-10 | Asahi Chem Ind Co Ltd | Composite semipermeable membrane and its production |
US4906374A (en) * | 1986-12-23 | 1990-03-06 | Pall Corporation | Filtration media with low protein adsorbability |
JPH01284303A (en) * | 1988-05-10 | 1989-11-15 | Asahi Chem Ind Co Ltd | High selectivity permeable membrane having hydrophilic property rendered to surface and production thereof |
US5788862A (en) * | 1992-05-13 | 1998-08-04 | Pall Corporation | Filtration medium |
EP0679167A1 (en) * | 1993-01-15 | 1995-11-02 | The Graver Company | Process for producing ion exchange membranes, and the ion exchange membranes produced thereby |
US5885456A (en) * | 1996-08-09 | 1999-03-23 | Millipore Corporation | Polysulfone copolymer membranes and process |
JP6633349B2 (en) * | 2015-10-29 | 2020-01-22 | 日東電工株式会社 | Separation membrane, membrane element and membrane module for bubble liquid concentration |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58189906A (en) * | 1982-04-30 | 1983-11-05 | 株式会社日立製作所 | Apparatus for supplying wire |
-
1986
- 1986-06-20 JP JP61142735A patent/JPH07121345B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58189906A (en) * | 1982-04-30 | 1983-11-05 | 株式会社日立製作所 | Apparatus for supplying wire |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3085815A1 (en) | 2013-12-18 | 2016-10-26 | Kawasaki Jukogyo Kabushiki Kaisha | Diaphragm for alkaline water electrolysis, method for producing same, and alkaline water electrolysis apparatus |
Also Published As
Publication number | Publication date |
---|---|
JPS631406A (en) | 1988-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH06104753B2 (en) | Non-adsorbing hydrophilic hollow fiber porous membrane | |
JP5011722B2 (en) | Method for producing medical separation membrane and method for producing medical separation membrane module using the medical separation membrane | |
JP4453248B2 (en) | Method for producing hollow fiber membrane and hollow fiber membrane module | |
JP5714852B2 (en) | Separation membrane, separation membrane module, method for producing separation membrane, and method for producing separation membrane module | |
WO2004035180A1 (en) | Microporous hydrophilic membrane | |
EP1439212B1 (en) | Hydrophilic material and process for producing the same | |
JPWO2002009857A1 (en) | Modified hollow fiber membrane | |
JPH0829234B2 (en) | Hydrophilic microporous membrane | |
JP6737565B2 (en) | Separation membrane for blood treatment and blood treatment device incorporating the membrane | |
WO2002034374A1 (en) | Hydrophilized membrane and method of hydrophilization therefor | |
CN112074340A (en) | Porous hollow fiber membrane | |
EP1410839B1 (en) | Hollow fiber membrane for purifying blood | |
JPH07121345B2 (en) | Non-adsorbing hydrophilic semipermeable membrane and method for producing the same | |
JP2006291193A (en) | Reformed substrate and manufacturing method thereof | |
JP3928910B2 (en) | Polysulfone blood treatment module | |
JP2686949B2 (en) | Selective adsorption functional microfilter and its manufacturing method | |
JP3216910B2 (en) | Porous hollow fiber membrane | |
JP6992111B2 (en) | Separation membrane for blood treatment and blood treatment device incorporating the membrane | |
JP4569315B2 (en) | Modified hollow fiber membrane | |
JPH0259029A (en) | Porous membrane having hydrophilic surface and preparation thereof | |
JPS6331501A (en) | Composite semipermeable membrane and its production | |
JP4433821B2 (en) | Modified substrate | |
CN106512749B (en) | It is a kind of for the two-sided modified seperation film of blood purification and its preparation, application method | |
JP2005065711A (en) | Absorption material and manufacturing method of the same | |
CN114845798B (en) | Porous separation membrane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |